MGNX - MacroGenics gains after mid-stage data for antibody drug conjugate
2024-04-04 06:56:09 ET
More on MacroGenics
- MacroGenics, Inc. (MGNX) Q4 2023 Earnings Call Transcript
- MacroGenics: Evaluating Its Buy Status After A 200% Surge On Prostate Cancer Prospects
- MacroGenics: Trying To Build A Better Everything
- MacroGenics Q4 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on MacroGenics